In an adaptive immune response, naive T cells proliferate during infection and generate long-lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000-fold in the liver after infection. After a contraction phase, Ly49H-positive NK cells reside in lymphoid and non-lymphoid organs for several months. These self-renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.
During an infection, naive T cells proliferate in response to encounter with cognate ligand and mediate effector functions [1] [2] [3] [4] . This first phase of the adaptive immune response is known as the expansion phase. In many infectious models of T-cell priming in vivo, pathogen-specific T cells become activated and expand in number over the course of one week, undergoing more than ten divisions, and give rise to thousands of daughter cells capable of effector functions [5] [6] [7] . In the second phase, known as 'contraction', the activated T cells undergo apoptosis; a precipitous drop in cell numbers (90-95%) is observed in all tissues 6, 8 . The third, or 'memory maintenance', phase 3, [9] [10] [11] is when stable populations of long-lived memory T cells reside in lymphoid and nonlymphoid tissues 12, 13 , patrolling against previously encountered pathogens. The fourth and last phase, the secondary or recall response, occurs when memory T cells re-encounter their cognate antigen and again robustly expand in numbers to fight the pathogen challenge 1, 4 . These four phases are ascribed to cells of the adaptive immune system, and the latter two phases have not been previously documented in NK cells.
NK cells have many traits in common with CD8 1 T cells [14] [15] [16] . The existence of immunological memory in NK cells has recently been suggested in a model of chemical hapten-induced contact hypersensitivity 17 ; however, the precise mechanism and identity of the antigen-specific receptors responsible for mediating the recall responses were not defined. Here, using the well-established model of mouse cytomegalovirus (MCMV) infection in which NK cells provide host protection, we show that NK cells undergo all four phases of an immune response against a pathogen.
NK-cell expansion and contraction phases
The early virus-specific immune response against MCMV in C57BL/6 (B6) mice is dominated by NK cells expressing the Ly49H receptor, which recognizes the virally encoded m157 protein on the surface of infected cells, and these NK cells confer protection against infection [18] [19] [20] [21] [22] . Over the first week of MCMV infection, Ly49H 1 NK cells undergo a twofold to threefold expansion in the spleen and a roughly tenfold increase in the liver, as described previously 23, 24 (Supplementary Fig. 1 ). Because Ly49H 1 cells constitute about 50% of total NK cells in a naive B6 mouse, we proposed that a 'ceiling' for NK-cell expansion (measured at 80-90% of total NK cells) is rapidly achieved during infection and inhibits further proliferation in a normal host. We therefore sought to investigate the proliferation potential of NK cells by experimentally decreasing the initial precursor frequency of the Ly49H 1 -cell population. We reconstituted lethally irradiated mice with 1:1 mixed bone marrow from wild-type (CD45.1 1 ) and DAP12-deficient (Tyrobp 2/2 ) (CD45.2 1 ) B6 mice (which are defective in Ly49H receptor expression and function 25 ), thus decreasing the initial frequency of fully functional, wild-type Ly49H 1 cells in the host to about 25% of the total NK cells ( Fig. 1a ). After infection of mixed chimaeric mice, wild-type NK cells preferentially expanded over 7 days and became the predominant NK-cell subset in the spleen (Fig. 1a ). Although the chimaeric mice contained a lower initial frequency of Ly49H 1 NK cells than the wild-type mice, by day 7 after infection the chimaeric mice had absolute numbers of Ly49H 1 NK cells that were comparable to those in infected wild-type mice (data not shown). The Ly49H 1 cells within the CD45.1 1 NK-cell fraction upregulated the expression of the maturation marker KLRG1 ( Fig. 1a ) and preferentially incorporated bromodeoxyuridine over 7 days after infection ( Fig. 1b) , confirming the proliferation of this specific NKcell subset and excluding the possibility that DAP12-deficient NK-cell populations were diminishing. Indeed, the absolute number of DAP12-deficient NK cells increased only slightly over the course of the infection (data not shown). The percentage of Ly49H 1 NK cells began to decline beyond day 7 after infection but continued to be elevated, compared with uninfected animals, at 15 and 28 days after infection; frequencies returned to those measured in uninfected animals by 37 days after infection ( Fig. 1c ). Similar expansion and contraction of Ly49H 1 NK cells were measured in the liver and lymph nodes of chimaeric mice during infection ( Supplementary Fig. 2 ). The Ly49H 1 NK-cell response was specific for the m157 viral ligand because we did not observe preferential expansion of the Ly49H subset during infection with MCMV lacking m157 ( Fig. 1d ). In 1:5 wildtype:DAP12-deficient bone marrow chimaeric mice, in which the starting percentage of wild-type Ly49H 1 cells was about 10% of total NK cells, the Ly49H 1 NK cells also preferentially expanded over 7 days after infection, allowing the wild-type (CD45.1 1 ) NK cells to constitute the dominant population observed at the peak of expansion ( Supplementary Fig. 3a ). This expansion of Ly49H 1 NK cells after infection observed in the spleen and liver was even greater than the proliferation measured in the 1:1 chimaeras ( Supplementary Fig. 3b ). Together, these findings highlight the ability of a small number of precursor NK cells to expand robustly into effector cells and mount a primary response against viral infection.
We next sought to address whether maximal proliferation of Ly49H 1 NK cells could be achieved by adoptively transferring mature wild-type NK cells (CD45.1 1 ) into DAP12-deficient mice (CD45.2 1 ) and infecting with MCMV ( Fig. 2a ). Although DAP12deficient mice have defective Ly49H 1 NK cells, CD8 1 T-cell responses to MCMV are normal, and mice clear infection within two weeks (data not shown). We were able to recover the transferred NK cells from recipient spleen ( Fig. 2b ) and thereby showed that early after infection (day 1.5 after infection), they were capable of becoming activated (CD69 1 and NKG2D high ) and producing interferon (IFN)-c ( Fig. 2b ). Seven days after infection, we observed a marked increase in transferred NK cell numbers, with preferential expansion in the Ly49H 1 NK-cell subset ( Fig. 2c ). Adoptive transfer of carboxyfluorescein succinimidyl ester (CFSE)-labelled NK cells confirmed that only the Ly49H 1 NK cells were dividing, fully diluting their CFSE during the 7 days after infection, whereas the Ly49H 2 NK-cell subset remained CFSE high (Fig. 2d ). NK cells transferred into DAP12deficient mice expanded as much as 100-fold in the spleen after infection ( Fig. 2e ). This expansion was not seen when NK cells were adoptively transferred into wild-type B6 mice, which contain competing endogenous Ly49H 1 NK cells and thus restrict proliferation of the transferred cells ( Fig. 2e ). The expansion of Ly49H 1 NK cells was not unique to DAP12-deficient recipients because we also observed robust expansion of Ly49H 1 NK cells when they were adoptively transferred into C57BL/6 mice that do not possess the Ly49h gene (data not shown).
The amplitude and kinetics of the MCMV-specific NK-cell response measured in our system mirror analogous responses in primary T cells 7, 26 , as well as with adoptive transfer of T-cell antigen receptortransgenic T cells 5, 27 . Furthermore, adoptive transfer of NK cells permits us to track the congenic CD45.1 1 cells late after infection, allowing us to distinguish between antigen-experienced NK cells and naive NK cells that have recently left the bone marrow. Using this experimental approach, we were able to recover a long-lived 'memory' pool of NK cells that can persist in lymphoid tissues as well as nonlymphoid tissues such as the liver (Fig. 3a, b ). We examined whether lowering the precursor frequency permitted a greater expansion of NK cells by measuring the amplitude of the Ly49H 1 NK-cell response in mice after the transfer of 10 5 or 10 4 cells, and determined that both the kinetics and fold expansion were comparable in the spleen (about 100fold) and liver (about 1,000-fold) of MCMV-infected mice, irrespective of initial transfer numbers ( Fig. 3a, b) . A lower threshold therefore exists at which small numbers of precursor NK cells no longer lead to enhanced overall responses. A summary of Ly49H 1 NK-cell fold expansion in B6 mice, the different mixed chimaeric mice and the adoptive transfer system is shown in Fig. 3c , highlighting the previously underappreciated ability of antigen-specific NK cells to undergo a profound expansion and persist after viral infection.
NK-cell memory phase
In our adoptive transfer model, the contraction phase observed during the NK-cell response to MCMV infection ( Fig. 3a, b ) seems to emulate the prolonged decline in effector-cell numbers observed with antigenspecific CD4 T-cell responses 26 , rather than the rapid and more precipitous decline observed with most CD8 1 T-cell responses 8 . After the contraction phase, we were able to detect 'memory' NK cells at 70 days after infection (Fig. 4a ), and we sought to determine whether these cells were still functional. These 'memory' NK cells were indeed functional, because they produced IFN-c ex vivo in response to platebound antibody against NK1.1 or Ly49H (Fig. 4a ). In fact, their response was heightened in comparison with the response by naive NK cells, in that a greater percentage of 'memory' NK cells responded to plate-bound antibodies as well as m157-expressing target cells, and the amounts of IFN-c produced by individual cells were higher ( Fig. 4b and Supplementary Fig. 4 ). Degranulation by 'memory' NK cells was also enhanced, as assessed by LAMP-1 (CD107a) expression after ex vivo stimulation with anti-NK1.1 (Fig. 4c ).
'Memory' Ly49H 1 NK cells could be distinguished from naive Ly49H 1 NK on the basis of several surface antigens. In particular, 'memory' NK cells expressed higher levels of the Ly49H receptor, but not other activating receptors, than naive NK cells ( Fig. 4d ), perhaps permitting 'memory' NK cells to have a lower threshold for activation. 'Memory' NK cells also showed a greater expression of KLRG1, CD43 and Ly6C, and a decreased expression of CD27, suggesting that they were more mature than naive NK cells ( Fig. 4d ). A similar phenotype was also observed on long-lived NK cells isolated from non-lymphoid tissues such as the liver ( Supplementary Fig. 5 ). 'Memory' NK cells also constitutively expressed higher levels of Ifng transcripts than naive NK cells ( Fig. 4e) , as assessed by studies with the IFN-c reporter Yeti mice 28 . Taken together, these data indicate that 'memory' NK cells possess characteristics similar to those of memory T cells in both their phenotype and their ability to produce effector cytokines robustly. 
NK-cell recall phase
Antigen-specific memory T cells undergo secondary expansion, and we investigated whether 'memory' NK cells also possessed this adaptive immune characteristic. Because mice previously immunized with MCMV contain neutralizing antibodies and memory cytotoxic T lymphocytes, we could not challenge directly with a second dose of virus to examine recall responses. Therefore, after the primary expansion and contraction phase in our adoptive transfer model, we enriched for 'memory' Ly49H 1 NK cells (CD45.1 1 ) at 40-50 days after infection, adoptively transferred these cells into a second DAP12-deficient mouse (CD45.2 1 ) and infected it with MCMV ( Fig. 5a ). Although the transferred 'memory' NK cells were present in small numbers in uninfected recipients and at day 1.5 after infection, an expanded population of transferred Ly49H 1 NK cells could be readily detected at 7 and 14 days after infection (Fig. 5b) . Thus, like memory T cells, 'memory' NK cells are self-renewing, long-lived, and can mount a secondary response after viral challenge, with expansion measured at greater than 100-fold in the spleen (Fig. 5c ). When CFSE-labelled naive and 'memory' NK cells were transferred into separate DAP12-deficient recipient mice and proliferation kinetics were compared after MCMV infection, we observed a similar rate of CFSE dilution at day 3 after infection and found that both groups of NK cells were CFSE-negative (indicating at least ten divisions) by day 6 after infection (Fig. 5d ). Although large numbers of naive NK cells were easier to obtain and thus more cells were transferred into recipient animals than 'memory' NK cells, the kinetics and magnitude of expansion between naive and 'memory' NK-cell populations were comparable (Fig. 5d ). Overall, MCMV-specific NK-cell responses after adoptive transfer of normalized naive and 'memory' NK cell numbers showed no significant differences in the expansion and contraction phases (Fig. 5e ). Several careful studies of CD8 1 T-cell responses have also revealed similarities in naive and memory T-cell proliferation rates [29] [30] [31] [32] [33] , indicating that the increased memory T-cell responses could be attributed to a higher precursor frequency rather than a differential rate of proliferation. Although phenotypic and functional differences exist between naive and 'memory' NK cells, it is not surprising that the kinetics of expansion between these populations do not differ, given the property of naive NK cells as 'ready-to-respond' effectors 14 . In fact, memory CD8 1 T cells have often been compared to NK cells for their ability to mediate effector functions rapidly 14 .
Last, we wished to determine whether 'memory' NK cells are more protective than naive NK cells. We adoptively transferred equal numbers of naive and 'memory' Ly49H 1 NK cells into newborn mice, which are susceptible to MCMV because they lack mature NK cells 34 , challenged them with MCMV, and monitored survival. Newborn mice receiving 'memory' NK cells showed significant protection against viral infection compared with an equivalent number of naive NK cells (P 5 0.0024; Fig. 5f ). At least tenfold more naive NK cells than 'memory' NK cells were required to mediate protection against MCMV infection. When newborn recipients were treated with an antibody that blocks the Ly49H receptor, protection was abrogated (P 5 0.03; Fig. 5f ). Thus, like T cells, NK cells have the ability to 'remember' previously encountered pathogens and are able to mediate more efficient protective immunity against subsequent infection.
Conclusion
Because the innate immune system is considered to be evolutionarily older than the adaptive immune system, NK cells bearing receptors that recognize major histocompatibility complex (MHC) and MHClike molecules may have arisen as a predecessor to T cells, which express clonally selected receptors for the recognition of a limitless antigen repertoire in the context of MHC. Alternatively, NK cells may have co-evolved with T cells. As an evolutionary bridge, NK cells might conceivably possess attributes of both innate and adaptive immunity, and we are only beginning to unearth characteristics of the latter. The categorization of NK cells within the immune system is beginning to undergo a paradigm shift, which will have major implications for our approach to vaccination strategies for the generation of immunological memory against pathogens.
METHODS SUMMARY
Mice and infections. C57BL/6 and congenic CD45.1 1 mice were purchased from the National Cancer Institute. DAP12-deficient mice 25 , backcrossed 13 generations onto C57BL/6, were bred and maintained in accordance with the guidelines of the Institutional Animal Care and Use Committee. R. Locksley provided Yeti mice 28 . Mixed-bone-marrow chimaeric mice were generated as described 35 . Mice were infected by intraperitoneal injections of Smith strain MCMV (5 3 10 4 plaque-forming units (p.f.u.)) and MCMV-Dm157 (10 5 p.f.u.) (provided by U. Koszinowski) 36 . Newborn mice were infected with 2 3 10 3 p.f.u. of MCMV. NK-cell enrichment and adoptive transfer. NK cells were isolated with an NKcell Isolation Kit (Miltenyi Biotec) and injected intravenously into adult recipients or intraperitonally into neonatal recipients one day before viral infection. Newborn mice were given 50 mg of anti-Ly49H monoclonal antibody (mAb) 3D10 one day before infection. Ex vivo stimulation of NK cells. Tissue culture plates treated with N-(1-(2,3dioleoyloxyl)propyl)-N,N,N-trimethylammonium methylsulphate (Sigma) were coated with anti-NK1.1 or anti-Ly49H (provided by W. Yokoyama) and cells were incubated for 5 h at 37 uC in the presence of Golgiplug (BD Pharmingen), followed by staining for intracellular cytokines. NK cells were co-cultured with Ba/F3 cells or m157-transduced Ba/F3 (ref. 18 ) before intracellular cytokine staining. Flow cytometry. Fc receptors were blocked with 2.4G2 mAb before surface staining with indicated antibodies or isotype-matched control immunoglobulin (BD or eBiosciences). Staining with bromodeoxyuridine was performed with a BrdU Flow Kit (BD). Labelling of cells with CFSE was performed in accordance with the manufacturer's instructions (Invitrogen). Samples were acquired on an LSRII (BD) and analysed with FlowJo software (TreeStar). Statistical methods. The Mann-Whitney nonparametric U-test was used to compare survival between groups of mice. A value of 25 days was assigned to survivors living more than 25 days after MCMV infection. Student's t-test was used to compare groups in ex vivo stimulation experiments.
